How Dialysis Removes Waste and Fluid from Body Compartments
Dialysis removes waste solutes and excess fluid primarily from the intravascular compartment through diffusion and convection across a semi-permeable membrane, with subsequent refilling from the interstitial and intracellular spaces driven by concentration gradients and osmotic forces.
Fundamental Mechanisms of Solute Removal
Dialysis employs three primary transport mechanisms 1:
Diffusion: Small molecules (urea, creatinine, potassium) move rapidly across the dialyzer membrane down their concentration gradient from blood to dialysate. This is the dominant mechanism for small solute clearance 2.
Convection: Water movement across the membrane carries dissolved solutes with it (solvent drag). This becomes increasingly important for middle-sized molecules (β2-microglobulin, inflammatory mediators) that diffuse poorly 3, 4.
Adsorption: Some solutes bind to the membrane surface, though this plays a minor role compared to diffusion and convection 1.
Compartmental Fluid Dynamics
The body's fluid exists in three compartments that interact during dialysis 5:
Intravascular Compartment (Direct Removal)
- Blood flows through the dialyzer where ultrafiltration directly removes plasma water
- Solutes are cleared simultaneously through diffusion and convection
- This is the only compartment directly accessed by the dialyzer
Interstitial to Intravascular Refilling
- As plasma volume decreases, hydrostatic and oncotic pressure gradients drive fluid from the interstitial space into capillaries
- The capillary filtration coefficient (Lp) determines the rate of this refilling 5
- Inadequate refilling causes intradialytic hypotension—a key clinical pitfall
Intracellular to Interstitial Movement
- Solute concentration gradients (especially sodium and urea) drive water movement from cells to interstitium
- The Na-K-ATPase pump actively transports sodium and potassium across cell membranes, creating osmotic gradients 5
- Intracellular volume changes occur more slowly than extracellular shifts
Critical Limitation: Intracorporeal Resistance
The rate-limiting step in dialysis is not the dialyzer's clearance capacity but rather the movement of solutes from tissues into the bloodstream 4. This "intracorporeal resistance" explains why:
- Simply increasing dialyzer efficiency has diminishing returns
- Longer or more frequent treatments are needed to overcome tissue-to-blood barriers 2, 4
- Middle molecules accumulate despite adequate small solute clearance
Protein-Bound Toxins: A Persistent Challenge
Protein-bound uremic toxins (PBUTs) remain largely trapped in the intravascular space because:
- They bind tightly to albumin, which cannot cross the dialyzer membrane
- Only the free (unbound) fraction can be removed
- Compartmental redistribution is slow, limiting removal even with convective therapies 3
This represents a major unresolved problem in dialysis adequacy 3.
Volume Management Across Modalities
Hemodialysis
Ultrafiltration removes fluid directly from plasma through hydrostatic pressure gradients across the dialyzer membrane. The hydraulic permeability of the membrane determines ultrafiltration capacity 1. Volume control requires addressing interdialytic weight gain and adjusting treatment time/frequency 6.
Peritoneal Dialysis
The peritoneal membrane serves as the dialyzer, with fluid removal driven by:
- Osmotic ultrafiltration: Glucose in dialysate creates an osmotic gradient pulling water from peritoneal capillaries
- Free water transport: Water moves through aquaporin-1 channels in capillary endothelium via crystalloid osmosis 7
- Hydrostatic ultrafiltration: Through inter-endothelial pores 7
A critical pitfall: Long-term glucose exposure causes peritoneal fibrosis and increased GLUT-1 expression, reducing the osmotic gradient and causing ultrafiltration failure 7.
Clinical Implications for Adequacy
Small solute clearance (measured by Kt/V for urea) remains the foundation of dialysis adequacy assessment 2. However, optimization should not stop there—middle molecule clearance (using β2-microglobulin as a surrogate) provides a more comprehensive adequacy target 4.
High-volume hemodiafiltration (≥23L convection volume per session) offers superior middle molecule removal and may reduce inflammation through enhanced clearance of inflammatory mediators 3. This modality shows the most consistent clinical benefits when adequate infrastructure and monitoring are available 3.
The interplay between compartments means that increasing treatment time and frequency is the only reliable way to overcome intracorporeal barriers to solute removal 4. This explains why more frequent or extended dialysis sessions improve volume control and blood pressure management beyond what can be achieved by simply increasing dialyzer efficiency 2, 6.